Year To Quarter End Consolidated Statement Of Comprehensive Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7543334

Concept 2023-03-01 to
2023-08-31
2022-03-01 to
2022-08-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
8,671,000,000 JPY
6,720,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
4,422,000,000 JPY
1,015,000,000 JPY
Foreign currency translation adjustment
8,303,000,000 JPY
12,996,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-93,000,000 JPY
-160,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
97,000,000 JPY
-26,000,000 JPY
Other comprehensive income
12,729,000,000 JPY
13,826,000,000 JPY
Comprehensive income
21,400,000,000 JPY
20,546,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
21,036,000,000 JPY
20,392,000,000 JPY
Comprehensive income attributable to non-controlling interests
364,000,000 JPY
153,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.